Tissue Regenix Group plc (TRX) ORD GBP0.001

- Add to watchlist
- Create an alert
- This stock can be held in a




29.50p
30.00p
74.00p
£21.01 million
29.50p
29.00p
29.50p
n/a
1.50p (4.84%) Previous:
1.50p
1,235,135
n/a
2,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2024 | 31/12/2023 |
---|---|---|
Revenue ($m) | 28.65 | 26.32 |
Profit before tax ($m) | (0.56) | (1.89) |
Adjusted EPS (¢): | (1.20) | (2.67) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Tissue Regenix gets CE, UKCA certifications for OrthoPure XT
9 June 2025 15:39
-
Tissue Regenix flags first half in line with expectations
16 July 2024 15:37
-
Tissue Regenix purchases building at Texas site
14 June 2024 09:58
-
Posting of Annual Report & Notice of AGM
27 June 2025 07:00
-
Final results for the year ended 31 December 2024
25 June 2025 07:00
-
CE & UKCA certification for OrthoPure® XT
9 June 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.